MEC Plus

Updates in CAR T Therapies
Updates in CAR T Therapies
Naseem Esteghamat, MD
Burkitt Lymphoma
Burkitt Lymphoma
Leidy Isenalumhe, MD
Double Hit Lymphomas
Double Hit Lymphomas
Julio Chavez, MD, MS
CNS Lymphomas
CNS Lymphomas
Sepideh Mokhtari, MD
Current Standard of Therapies in CLL
Current Standard of Therapies in CLL
Javier Pinilla-Ibarz, MD, PhD
New Strategies for MCL
New Strategies for MCL
Bijal Shah, MD, MS
Marginal Zone Lymphomas
Marginal Zone Lymphomas
Sameh Gaballa, MD
Current Status of Cervical Cancer Screening
Current Status of Cervical Cancer Screening
Ritu Salani MD, MBA
Role of ADCs in Gynecological Malignancies
Role of ADCs in Gynecological Malignancies
Don S. Dizon, MD, FACP, FASCO
Ovarian Cancer: Beyond Carboplatin and Paclitaxel
Ovarian Cancer: Beyond Carboplatin and Paclitaxel
Alexander B. Olawaiye, MD, FRCOG, FACOG, FACS
Endocrine Therapy for Advanced Breast Cancer: Current and Future Strategies
Endocrine Therapy for Advanced Breast Cancer: Current and Future Strategies
Reshma L. Mahtani, DO
Endocrine Therapy and Targeted Agents for Early-Stage HR+ Breast Cancer
Endocrine Therapy and Targeted Agents for Early-Stage HR+ Breast Cancer
William J. Gradishar, MD, FACP
Antibody Drug Conjugates: New Agents and Optimal Sequencing
Antibody Drug Conjugates: New Agents and Optimal Sequencing
Hope S. Rugo, MD, FASCO
Immunotherapy for Breast Cancer: Updates and New Directions
Immunotherapy for Breast Cancer: Updates and New Directions
Mark Pegram, MD
Prostate Cancer: Role of PSMA PET and Accurately Defining “Neuroendocrine” Prostate
Prostate Cancer: Role of PSMA PET and Accurately Defining “Neuroendocrine” Prostate
Ravi A. Madan, MD
Role of Immunotherapy in HNC
Role of Immunotherapy in HNC
Hyunseok (Hyu) Kang, MD, MPH, FACP